The US Food and Drug Administration on 23 September granted emergency use authorization (EUA) to Assure Tech Co. Ltd. for its point-of-care serology test for COVID-19. It’s the first POC blood test for determining whether a person has been exposed to the SARS-CoV-2 virus.
The Assure COVID-19 IgG/IgM Rapid Test Device – originally issued an EUA in July for use only in labs –...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?